Product Information
DASATINIB 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $26.3180 per EA under NDC 59651054630. Its NADAC has been published 51 times since Jul 9, 2025.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651054630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DASATINIBApproval Type
Generic (ANDA)
FDA Application
ANDA216547On Market Since
4/22/2025
Pharmacological Classes
Price Statistics
The NADAC for DASATINIB 100 MG TABLET has been published 51 times since Jul 9, 2025, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.3180 per EA |
|---|---|
| All-time high | $191.7363 (Dec 10, 2025) |
| All-time low | $26.3180 (Jun 17, 2026) |
| 52-week high | $191.7363 |
| 52-week low | $26.3180 |
| Median price | $30.2487 |
| Average price | $102.3442 |
| Largest weekly change | -84.2% (Dec 17, 2025) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DASATINIB market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DASATINIB 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $26.3180 per EA (NDC 59651054630), effective Jun 24, 2026.
How has the price of DASATINIB 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 86.3%. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?
Since Jul 9, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $26.3180 (Jun 17, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $30.2487 per EA.
Are there cheaper alternatives to DASATINIB 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DASATINIB 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures DASATINIB 100 MG TABLET?
DASATINIB 100 MG TABLET (NDC 59651054630) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification